
Moberg Pharma AB (publ)
STO:MOB

Moberg Pharma AB (publ)?
US |
![]() |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
US |
![]() |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
US |
![]() |
Bank of America Corp
NYSE:BAC
|
Banking
|
US |
![]() |
Mastercard Inc
NYSE:MA
|
Technology
|
US |
![]() |
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
US |
![]() |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
US |
![]() |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
US |
![]() |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
US |
![]() |
Visa Inc
NYSE:V
|
Technology
|
CN |
![]() |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
US |
![]() |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
US |
![]() |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
US |
![]() |
Coca-Cola Co
NYSE:KO
|
Beverages
|
US |
![]() |
Walmart Inc
NYSE:WMT
|
Retail
|
US |
![]() |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
We'll email you a reminder when the closing price reaches USD.
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
7.625
38.92
|
Price Target |
|
We'll email you a reminder when the closing price reaches SEK.
Choose the stock you wish to monitor with a price alert.
![]() |
Johnson & Johnson
NYSE:JNJ
|
US |
![]() |
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
![]() |
Bank of America Corp
NYSE:BAC
|
US |
![]() |
Mastercard Inc
NYSE:MA
|
US |
![]() |
UnitedHealth Group Inc
NYSE:UNH
|
US |
![]() |
Exxon Mobil Corp
NYSE:XOM
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
US |
![]() |
Palantir Technologies Inc
NYSE:PLTR
|
US |
![]() |
Nike Inc
NYSE:NKE
|
US |
![]() |
Visa Inc
NYSE:V
|
US |
![]() |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
![]() |
3M Co
NYSE:MMM
|
US |
![]() |
JPMorgan Chase & Co
NYSE:JPM
|
US |
![]() |
Coca-Cola Co
NYSE:KO
|
US |
![]() |
Walmart Inc
NYSE:WMT
|
US |
![]() |
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.

What unique competitive advantages
does Moberg Pharma AB (publ) hold over its rivals?
What risks and challenges
does Moberg Pharma AB (publ) face in the near future?
Is it considered overvalued or undervalued
based on the latest financial data?
Provide an overview of the primary business activities
of Moberg Pharma AB (publ).
Provide an overview of the primary business activities
of Moberg Pharma AB (publ).
What unique competitive advantages
does Moberg Pharma AB (publ) hold over its rivals?
What risks and challenges
does Moberg Pharma AB (publ) face in the near future?
Has there been any significant insider trading activity
in Moberg Pharma AB (publ) recently?
Summarize the latest earnings call
of Moberg Pharma AB (publ).
Is it considered overvalued or undervalued
based on the latest financial data?
Show all valuation multiples
for Moberg Pharma AB (publ).
Provide P/S
for Moberg Pharma AB (publ).
Provide P/E
for Moberg Pharma AB (publ).
Provide P/OCF
for Moberg Pharma AB (publ).
Provide P/FCFE
for Moberg Pharma AB (publ).
Provide P/B
for Moberg Pharma AB (publ).
Provide EV/S
for Moberg Pharma AB (publ).
Provide EV/GP
for Moberg Pharma AB (publ).
Provide EV/EBITDA
for Moberg Pharma AB (publ).
Provide EV/EBIT
for Moberg Pharma AB (publ).
Provide EV/OCF
for Moberg Pharma AB (publ).
Provide EV/FCFF
for Moberg Pharma AB (publ).
Provide EV/IC
for Moberg Pharma AB (publ).
Show me price targets
for Moberg Pharma AB (publ) made by professional analysts.
What are the Revenue projections
for Moberg Pharma AB (publ)?
How accurate were the past Revenue estimates
for Moberg Pharma AB (publ)?
What are the Net Income projections
for Moberg Pharma AB (publ)?
How accurate were the past Net Income estimates
for Moberg Pharma AB (publ)?
What are the EPS projections
for Moberg Pharma AB (publ)?
How accurate were the past EPS estimates
for Moberg Pharma AB (publ)?
What are the EBIT projections
for Moberg Pharma AB (publ)?
How accurate were the past EBIT estimates
for Moberg Pharma AB (publ)?
Compare the revenue forecasts
for Moberg Pharma AB (publ) with those of its competitors based on recent analyst estimates.
Compare the intrinsic valuations
of Moberg Pharma AB (publ) and its key competitors using the latest financial data.
Compare historical revenue growth rates
of Moberg Pharma AB (publ) against its competitors.
Analyze the profit margins
(gross, operating, and net) of Moberg Pharma AB (publ) compared to its peers.
Compare the P/E ratios
of Moberg Pharma AB (publ) against its peers.
Discuss the investment returns and shareholder value creation
comparing Moberg Pharma AB (publ) with its peers.
Analyze the financial leverage
of Moberg Pharma AB (publ) compared to its main competitors.
Show all profitability ratios
for Moberg Pharma AB (publ).
Provide ROE
for Moberg Pharma AB (publ).
Provide ROA
for Moberg Pharma AB (publ).
Provide ROIC
for Moberg Pharma AB (publ).
Provide ROCE
for Moberg Pharma AB (publ).
Provide Gross Margin
for Moberg Pharma AB (publ).
Provide Operating Margin
for Moberg Pharma AB (publ).
Provide Net Margin
for Moberg Pharma AB (publ).
Provide FCF Margin
for Moberg Pharma AB (publ).
Show all solvency ratios
for Moberg Pharma AB (publ).
Provide D/E Ratio
for Moberg Pharma AB (publ).
Provide D/A Ratio
for Moberg Pharma AB (publ).
Provide Interest Coverage Ratio
for Moberg Pharma AB (publ).
Provide Altman Z-Score Ratio
for Moberg Pharma AB (publ).
Provide Quick Ratio
for Moberg Pharma AB (publ).
Provide Current Ratio
for Moberg Pharma AB (publ).
Provide Cash Ratio
for Moberg Pharma AB (publ).
What is the historical Revenue growth
over the last 5 years for Moberg Pharma AB (publ)?
What is the historical Net Income growth
over the last 5 years for Moberg Pharma AB (publ)?
What is the current Free Cash Flow
of Moberg Pharma AB (publ)?
Discuss the annual earnings per share (EPS)
trend over the past five years for Moberg Pharma AB (publ).
P/S
Price to Sales
Price to Sales (P/S) ratio is a valuation multiple that compares a company’s market capitalization to its revenues. It is an indicator of the value that financial markets have placed on each dollar of a company’s sales.
Market Cap | P/S | ||||
---|---|---|---|---|---|
SE |
![]() |
Moberg Pharma AB (publ)
STO:MOB
|
362.3m SEK | 36.9 | |
US |
![]() |
Eli Lilly and Co
NYSE:LLY
|
775.3B USD | 17.2 |
|
UK |
![]() |
Dechra Pharmaceuticals PLC
LSE:DPH
|
440.4B GBP | 578.3 |
|
US |
![]() |
Johnson & Johnson
NYSE:JNJ
|
373.9B USD | 4.2 |
|
DK |
![]() |
Novo Nordisk A/S
CSE:NOVO B
|
2.1T DKK | 7.1 |
|
CH |
![]() |
Roche Holding AG
SIX:ROG
|
223.9B CHF | 3.8 |
|
UK |
![]() |
AstraZeneca PLC
LSE:AZN
|
177.1B GBP | 4.3 |
|
CH |
![]() |
Novartis AG
SIX:NOVN
|
197.4B CHF | 4.3 |
|
US |
![]() |
Merck & Co Inc
NYSE:MRK
|
219.3B USD | 3.4 |
|
IE |
E
|
Endo International PLC
LSE:0Y5F
|
167.6B USD | 72.3 |
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
140B USD | 2.2 |
|
Revenue Growth | P/S to Growth | |||||
---|---|---|---|---|---|---|
SE |
![]() |
Moberg Pharma AB (publ)
STO:MOB
|
Average P/S:
66.7
36.9
|
138%
|
0.3 | |
US |
![]() |
Eli Lilly and Co
NYSE:LLY
|
17.2
|
22%
|
0.8 |
|
UK |
![]() |
Dechra Pharmaceuticals PLC
LSE:DPH
|
578.3
|
9%
|
64.3 |
|
US |
![]() |
Johnson & Johnson
NYSE:JNJ
|
4.2
|
3%
|
1.4 |
|
DK |
![]() |
Novo Nordisk A/S
CSE:NOVO B
|
7.1
|
17%
|
0.4 |
|
CH |
![]() |
Roche Holding AG
SIX:ROG
|
3.8
|
5%
|
0.8 |
|
UK |
![]() |
AstraZeneca PLC
LSE:AZN
|
4.3
|
7%
|
0.6 |
|
CH |
![]() |
Novartis AG
SIX:NOVN
|
4.3
|
3%
|
1.4 |
|
US |
![]() |
Merck & Co Inc
NYSE:MRK
|
3.4
|
5%
|
0.7 |
|
IE |
E
|
Endo International PLC
LSE:0Y5F
|
72.3
|
N/A | N/A |
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
2.2
|
0%
|
N/A |
|
P/S Forward Multiples
Forward P/S multiple is a version of the P/S ratio that uses forecasted revenue for the P/S calculation. 1-Year, 2-Years, and 3-Years forwards use revenue forecasts for 1, 2, and 3 years ahead, respectively.